(Q39471459)

12 September 2017

1 reference

title

Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients (English)

1 reference

12 September 2017

0 references

1 reference

Pickar D

1

1 reference

12 September 2017

Breier A

series ordinal

2

1 reference

12 September 2017

Kelsoe J

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

12 September 2017

published in

1 reference

12 September 2017

volume

537

1 reference

12 September 2017

page(s)

339-346

1 reference

Antipsychotic drug doses and neuroleptic/dopamine receptors

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

An anatomy of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Selective activation of mesocortical DA system by stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Influence of dopamine agonists on plasma and brain levels of homovanillic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Clinical and biochemical effects of verapamil administration to schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42118.X

10.1111/J.1749-6632.1988.TB42118.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference